PURPOSE: To examine the in vivo activation of nuclear factor (NF)-kappaB in mouse lens epithelia by using bacterial lipopolysaccharide (LPS), tumor necrosis factor (TNF)-alpha, and UV-B radiation. METHODS: Transgenic mice containing the NF-kappaB-luciferase reporter were injected with LPS, TNF-alpha or, exposed to UV-B. After various exposure times, the mice were killed, and ocular, liver, lung, kidney, spleen, and skin tissue were obtained. Tissue homogenates were examined for luciferase activity with a luminometer. Groups of mice were also imaged in vivo through a light-intensified camera system to assess NF-kappaB activity. RESULTS: LPS- and TNF-alpha injected NF-kappaB-luciferase transgenic mice yielded 20- to 40-fold increases in lens NF-kappaB activity, similar to other LPS- and TNF-alpha-responsive organs. Peak NF-kappaB activity occurred 6 hours after injection of TNF-alpha and 12 hours after injection of LPS. Peak activities were, respectively, 3 and 6 hours later than that in other tissues. Mice exposed to 360 J/m(2) of UV-B exhibited a 16-fold increase in NF-kappaB activity 6 hours after exposure, which are characteristics similar to TNF-alpha-exposed mice. In vivo imaging of transgenic mice exposed to LPS, TNF-alpha, and UV-B radiation demonstrated a similarity between in vitro and in vivo measurements of NF-kappaB activity. CONCLUSIONS: In NF-kappaB-luciferase transgenic mice, NF-kappaB activity occurs in lens epithelial tissue and is activated when the intact mouse is exposed to bacterial LPS, TNF-alpha, or UV-B. Lens epithelial NF-kappaB kinetics were comparable to those of other tissues, indicating that NF-kappaB may play a role in progression or arrest of lens disorders.
PURPOSE: To examine the in vivo activation of nuclear factor (NF)-kappaB in mouselens epithelia by using bacterial lipopolysaccharide (LPS), tumor necrosis factor (TNF)-alpha, and UV-B radiation. METHODS:Transgenic mice containing the NF-kappaB-luciferase reporter were injected with LPS, TNF-alpha or, exposed to UV-B. After various exposure times, the mice were killed, and ocular, liver, lung, kidney, spleen, and skin tissue were obtained. Tissue homogenates were examined for luciferase activity with a luminometer. Groups of mice were also imaged in vivo through a light-intensified camera system to assess NF-kappaB activity. RESULTS:LPS- and TNF-alpha injected NF-kappaB-luciferase transgenic mice yielded 20- to 40-fold increases in lens NF-kappaB activity, similar to other LPS- and TNF-alpha-responsive organs. Peak NF-kappaB activity occurred 6 hours after injection of TNF-alpha and 12 hours after injection of LPS. Peak activities were, respectively, 3 and 6 hours later than that in other tissues. Mice exposed to 360 J/m(2) of UV-B exhibited a 16-fold increase in NF-kappaB activity 6 hours after exposure, which are characteristics similar to TNF-alpha-exposed mice. In vivo imaging of transgenic mice exposed to LPS, TNF-alpha, and UV-B radiation demonstrated a similarity between in vitro and in vivo measurements of NF-kappaB activity. CONCLUSIONS: In NF-kappaB-luciferase transgenic mice, NF-kappaB activity occurs in lens epithelial tissue and is activated when the intact mouse is exposed to bacterial LPS, TNF-alpha, or UV-B. Lens epithelial NF-kappaB kinetics were comparable to those of other tissues, indicating that NF-kappaB may play a role in progression or arrest of lens disorders.
Authors: Nilesh M Kalariya; Mohammad Shoeb; Aramati B M Reddy; Min Zhang; Frederik J G M van Kuijk; Kota V Ramana Journal: Invest Ophthalmol Vis Sci Date: 2010-04-30 Impact factor: 4.799
Authors: Nilesh M Kalariya; Aramati B M Reddy; Naseem H Ansari; Frederik J G M VanKuijk; Kota V Ramana Journal: Invest Ophthalmol Vis Sci Date: 2011-07-11 Impact factor: 4.799
Authors: Amir I Tukhvatulin; Ilya I Gitlin; Dmitry V Shcheblyakov; Natalia M Artemicheva; Lyudmila G Burdelya; Maxim M Shmarov; Boris S Naroditsky; Andrei V Gudkov; Alexander L Gintsburg; Denis Y Logunov Journal: Infect Immun Date: 2013-07-29 Impact factor: 3.441
Authors: A I Tukhvatulin; D Y Logunov; I I Gitlin; M M Shmarov; P V Kudan; Capital A Cyrillic А Adzhieva; A F Moroz; N N Kostyukova; L G Burdelya; B S Naroditsky; A L Gintsburg; A V Gudkov Journal: Acta Naturae Date: 2011-01 Impact factor: 1.845
Authors: Mohammad Shoeb; Min Zhang; Tianlin Xiao; Misha F Syed; Naseem H Ansari Journal: Invest Ophthalmol Vis Sci Date: 2018-01-01 Impact factor: 4.799
Authors: Nurul Alimah Abdul Nasir; Renu Agarwal; Siti Hamimah Sheikh Abdul Kadir; Sushil Vasudevan; Minaketan Tripathy; Igor Iezhitsa; Aqil Mohammad Daher; Mohd Ikraam Ibrahim; Nafeeza Mohd Ismail Journal: PLoS One Date: 2017-03-28 Impact factor: 3.240